Yeda (former YoniCore)’s Post

#Medtech Company CardioSignal secures $10 million in series A round funding. This round was led by DigiTx Partners, with participation from Sandwater and existing investor Maki.vc. David J. Kim, M.D., managing director of DigiTx, will be joining the board. To-date, CardioSignal has raised $23 million. The Series A investment will fund additional clinical #validation of CardioSignal’s breakthrough technology and the expansion of its #commercial efforts. CardioSignal develops digital technologies and software-as-medical-devices to provide early detection of #heart diseases, and provides the first and only technology to detect several major heart diseases with high #accuracy using just one clinical #modality without any specialized medical equipment. CardioSignal is a brand and a product by #Precordior Ltd, an ISO 13485 and 27001 certified health technology company formed in 2017 and headquartered in Turku, #Finland. CardioSignal by Precordior DigiTx Partners Sandwater Maki.vc Juuso Blomster To share your startup story write us on - [email protected] #cardiosignal #funding #startup

In my latest article published on MD DI, I share tips from 5 startup #medtech CEOs on how to convince a variety of stakeholders on the path to getting your #medicaldevice to market. Highlights from this op-ed include: ➡️ Shyam Natarajan, CEO of Avenda Health, stresses why it’s important to never stop talking to end users in order to figure out the scale of the need you’re trying to solve. ➡️ Cecile Brosset Dubois, CEO of Sonio, talks about customizing your pitch to resonate with the diverse interests and priorities of potential investors. ➡️ Kelly Roman, CEO of Fisher Wallace Laboratories, Inc., elaborates on the exploration of fundraising and market opportunities through pilot study programs, crowdfunding, and other unconventional routes. ➡️ Patricia Zilliox, former CEO of EYEVENSYS, emphasizes the criticality of developing treatments that are not only scientifically sound but patient-friendly, too. ➡️ Eugene Malinskiy, CEO of Lazurite, tells his story about working closely with physicians during the earliest development stages in order to land on a product that serves the needs, preferences, and workflow of all end-users. For more actionable advice from these proven leaders, check out the full article here: https://lnkd.in/gtJG497C As always, thanks to Omar Ford, Amanda Pedersen, and Katie Hobbins for their publishing support! 🙌🏼

30 Top Health Tech Startups & Companies To Watch 2024 Noteworthy changes are taking place in the healthcare industry. Many health companies use the newest technology to develop remarkable ideas that will change the field. This tsunami of innovative ideas is changing healthcare delivery and experience. The healthcare market was valued at 7.9 trillion Dollars the previous year. Let's examine 30 innovative health tech startups and enterprises changing this year. for more information, visit; https://lnkd.in/gxaMN55i #owebesttechnology #appdevelopmentcompany #appdevelopment #HealthTech #HealthcareInnovation #MedTech #HealthStartups #DigitalHealth #HealthCareRevolution #TechInHealth #FutureOfHealth #HealthCareTech #HealthInnovation #HealthTech2024 #MedStartups #HealthCareTransformation #SmartHealth #HealthTechNews #HealthCareStartups #InnovativeHealth #HealthTechTrends #HealthTechInnovation #HealthTechCompanies #HealthTechStartups

One thing that stood out for me in GSR Ventures' recent survey was how ophthalmology was called out by VCs as holding the least opportunity for #healthtech #startups. So we ran a physician poll to see if there's any substance to this claim and looks like they're onto something. Nearly 60% of ophthalmologists that took part in our poll claim they do not use any AI software/tools in their day-to-day clinical practice. While the remainder who do use AI to varying degrees in their clinic are overall positive about the utility of digital technologies in improving diagnosis and treatment planning (our poll highlights the top use cases of AI/digital tech among these ophthalmologists), that's still a sizeable chunk of this medical specialty who are AI- and new tech-resistant. Why do you think that is? I'd love to hear comments from the many out there who are more knowledgeable than me or have a better understanding of the ophthalmology field. I don't think this should put off startups whose tech could be ultimately beneficial to ophthalmic patients - don't forget, age-related eye conditions (think cataracts, glaucoma, AMD and other retinal diseases) represent a HUGE commercial opportunity. Tech developers just have to work harder to educate this clinical community. Agree? #startups #innovation #marketopportunity #digitalhealth #medicalAI #opthalmology #innovators #virtualcare

Here are some tried and true lessons that Scott Nelson summarised in a recent op-ed for MD DI. In this article, he explores how #medtech startups can move from idea to commercialization and what it takes to convince key stakeholders along the way. In addition to the 5 key learnings he shares from other #medicaldevices entrepreneurs, Scott also touches on: 🪺 Strategies for gathering evidence and that can help inform your decisions. 🎨 The power of storytelling in all stages of a startup. 🔩 Using prototypes to demonstrate the viability of your idea. Click on the link ⬇ to check out the full article.

Hello #HealthTech enthusiasts! We've just dropped an in-depth article expanding on the head-turning medical startups that are reshaping Hovedstaden's Healthcare Landscape in 2023. Find out more about how these entrepreneurs are revolutionizing the future of Healthcare. Read more here: https://lnkd.in/eEvcxb2p Featuring: Egoo.Health founded by Ebbe Finding, Lars Bangsgaard, Peter W. Enduro Genetics Ciana Therapeutics ApS HHC medical founded by Alexander Viterbo-Horten, Carl Frederik Haugaard, Niels Clausen CBio Zerion Pharma founded by Adam Bohr, Jorrit Jeroen Water GLX ANALYTIX founded by Brian Della Valle SyncSense MoreMemo BOOST Pharma BrainCapture Lægeforeningen Blue Cell Therapeutics Fermexa Metabolyzer Let's give these startups our full support as they explore new frontiers in the HealthTech industry. Join the conversation and let us know which startup you believe will make the biggest impact! #Startups #Innovation #Healthcare

Estonian startup Nanordica Medical raises €1.75M for advanced wound care Tallinn-based medtech startup Nanordica Medical has secured €1.75 million in funding to bring its pioneering wound care products to market. Led by Specialist VC with participation from Superangel and Amalfi, the investment will support the launch of Nanordica’s advanced antibacterial dressings, designed to treat severe wounds more effectively. Combining copper and silver nanoparticles, their solution offers up to eight times better bacterial inactivation compared to traditional treatments, significantly improving healing times for conditions such as diabetic foot ulcers. Additionally, Nanordica Medical was recognized as a top contender, placing in the top three at last year’s Arctic15 pitch competition, our annual event that brings together the startup ecosystem. https://lnkd.in/dYs7VJfX #balticmade #estonia #funding #startups #medtech #deeptech #healthtech #diabetes #trending

Medical Microinstruments (MMI) Raises $110 Million To Increase Treatment Options And Improve Clinical Outcomes #Innovation #Startups #VentureCapital #MedicalMicroinstruments #MMI